Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
Abstral (fentanyl sublingual tablets)
|
breakthrough cancer pain in opioid-tolerant patients
|
|
Actemra (tocilizumab)
|
systemic juvenile idiopathic arthritis
(2010: adult rheumatoid arthritis) |
|
Adcretris (brentuximab vedotin)
|
Hodgkin lymphoma and anaplastic large cell lymphoma
|
|
Afinitor (everolimus)
|
advanced pancreatic neuroendocrine tumors [2011]
(other oncology and transplant indications in different years) |
|
Anturol (oxybutynin) Gel
|
overactive bladder
|
|
Arcapta (indacaterol maleate inhalation powder)
|
airflow obstruction resulting from chronic obstructive pulmonary disease
|
|
Benlysta (belimumab)
|
systemic lupus erythematosus
|
|
Brilinta (ticagrelor)
|
reduction of thrombotic events in patients with acute coronary syndrome
|
|
Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate)
|
HIV-1 in treatment-naive adults
|
|
Daliresp (roflumilast)
|
chronic obstructive pulmonary disease
|
|
Dificid (fidaxomicin)
|
Clostridium difficile-associated diarrhea
|
|
Duexis (ibuprofen and famotidine)
|
rheumatoid arthritis and osteoarthritis and prevention of gastric ulcers
|
|
Edarbi (azilsartan medoxomil)
|
hypertension
|
|
Edarbyclor (azilsartan medoxomil and chlorthalidone)
|
hypertension
|
|
Edurant (rilpivirine)
|
HIV-1
|
|
Exparel (bupivacaine liposome injectable suspension)
|
postsurgical analgesia
|
|
Eylea (aflibercept)
|
neovascular (wet) age-related macular degeneration
|
|
Erwinaze (asparaginase Erwinia chrysanthemi)
|
acute lymphoblastic leukemia
|
|
Ferriprox (deferiprone)
|
transfusional iron overload due to thalassemia
|
|
Firazyr (icatibant)
|
acute attacks of hereditary angioedema
|
|
Gralise (gabapentin)
|
postherpetic neuralgia
|
|
Horizant (gabapentin enacarbil)
|
restless legs syndrome
|
|
Incivek (telaprevir)
|
genotype 1 chronic hepatitis C
|
|
Intermezzo (zolpidem tartrate sublingual tablet)
|
insomnia
|
|
Jakafi (ruxolitinib)
|
myelofibrosis
|
|
Juvisync (sitagliptin and simvastatin)
|
type II diabetes
|
|
Laviv (azficel-T)
|
nasolabial fold wrinkles in adults
|
|
Lazanda (fentanyl citrate) nasal spray
|
breakthrough cancer pain
|
|
Makena (hydroxyprogesterone caproate injection)
|
prevention of risk of preterm birth
|
|
Onfi (clobazam)
|
adjunctive treatment of seizures associated with Lennox-Gastaut syndrome
|
|
Oxecta (oxycodone HCl)
|
acute and chronic moderate to severe pain
(formulated to discourage abuse; can't crush, snort, inject) |
|
Potiga (ezogabine)
|
partial-onset seizures
|
|
Rectiv (nitroglycerin) ointment 0.4%
|
chronic anal fissure
|
|
Soliris (eculizumab)
|
atypical hemolytic uremic syndrome
|
|
Sutent (sunitinib malate)
|
pancreatic neuroendocrine tumors
(advanced renal cell carcinoma, 2006) |
|
Sylatron (peginterferon alfa-2b)
|
melanoma
|
|
Tradjenta (linagliptin)
|
type II diabetes
|
|
Vandetanib (vandetanib)
|
thyroid cancer
|
|
Victrelis (boceprevir)
|
chronic hepatitis C genotype 1
|
|
Viibryd (vilazodone hydrochloride)
|
major depressive disorder
|
|
Xalkori (crizotinib)
|
ALK+ non-small cell lung cancer
|
|
Xarelto (rivaroxaban)
|
reduction in the risk of stroke and systemic embolism resulting from atrial fibrillation, also DVT prophylaxis during knee or hip replacement surgery
|
|
Yervoy (ipilimumab)
|
metastatic melanoma
|
|
Zelboraf (vemurafenib)
|
BRAF + melanoma
|
|
Zytiga (abiraterone acetate)
|
prostate cancer
|